Regeneron CEO: There are structural issues around drug pricing in society

Len Schleifer, Regeneron founder and CEO, speaks to CNBC's Meg Tirrell about prescription drug pricing and his thoughts on potential government regulation on the sector.
03:47
Wed, Mar 28 20182:40 PM EDT